Literature DB >> 21645151

Cholesterol esters as growth regulators of lymphocytic leukaemia cells.

M F Mulas1, C Abete, D Pulisci, A Pani, B Massidda, S Dessì, A Mandas.   

Abstract

OBJECTIVE: Alterations in plasma lipid profile and in intracellular cholesterol homoeostasis have been described in various malignancies; however, significance of these alterations, if any, in cancer biology is not clear. The aim of the present study was to investigate a possible correlation between alterations in cholesterol metabolism and expansion of leukaemia cell numbers.
MATERIALS AND METHODS: Lipid profiles in plasma and in primary leukaemia cells isolated from patients with acute or chronic lymphocytic leukaemia (ALL and CLL) were studied. RESULTS AND
CONCLUSIONS: Decreased levels of HDL-C were observed in plasma of leukaemic patients, levels of total cholesterol, LDL-C, triglycerides and phospholipids were unchanged or only slightly increased. As compared to normal lymphocytes, freshly isolated leukaemic cells showed increased levels of cholesterol esters and reduction in free cholesterol. Growth stimulation of ALL and CLL cells with phytohemagglutinin led to further increase in levels of cholesterol esters. Conversely, treatment with an inhibitor of cell proliferation such as the mTOR inhibitor, RAD, caused decline in population growth rate of leukaemia cells, which was preceded by sharp reduction in rate of cholesterol esterification. On the other hand, exposure of leukaemic cells to two inhibitors of cholesterol esterification, progesterone and SaH 58-035, caused 60% reduction in their proliferation rate. In addition to demonstrating tight correlation between cell number expansion and cholesterol esterification in leukaemic cells, these results suggest that pathways that control cholesterol esterification might represent a promising targets for novel anticancer strategies.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645151      PMCID: PMC6496738          DOI: 10.1111/j.1365-2184.2011.00758.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  43 in total

Review 1.  The role of cholesterol in malignancy.

Authors:  H W Chen; A A Kandutsch; H J Heiniger
Journal:  Prog Exp Tumor Res       Date:  1978

Review 2.  Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity.

Authors:  G C Ness; C M Chambers
Journal:  Proc Soc Exp Biol Med       Date:  2000-05

3.  c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.

Authors:  J S Biscardi; M C Maa; D A Tice; M E Cox; T H Leu; S J Parsons
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

4.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

5.  Abnormal cholesterol metabolism in renal clear cell carcinoma.

Authors:  R L Gebhard; R V Clayman; W F Prigge; R Figenshau; N A Staley; C Reesey; A Bear
Journal:  J Lipid Res       Date:  1987-10       Impact factor: 5.922

6.  Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.

Authors:  M Rudling; M Gåfvels; P Parini; G Gahrton; B Angelin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 7.  Annexins--modulators of EGF receptor signalling and trafficking.

Authors:  Thomas Grewal; Carlos Enrich
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

8.  HDL subfractions as altered in cancer patients.

Authors:  C Anchisi; B Batetta; F Sanna; A M Fadda; A M Maccioni; S Dessi
Journal:  J Pharm Biomed Anal       Date:  1995-01       Impact factor: 3.935

9.  Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.

Authors:  E A Musgrove; C S Lee; M F Buckley; R L Sutherland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies.

Authors:  S Dessì; B Batetta; O Spano; F Sanna; M Tonello; M Giacchino; L Tessitore; P Costelli; F M Baccino; E Madon
Journal:  Clin Sci (Lond)       Date:  1995-11       Impact factor: 6.124

View more
  32 in total

Review 1.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

2.  Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.

Authors:  Shuhua Yue; Junjie Li; Seung-Young Lee; Hyeon Jeong Lee; Tian Shao; Bing Song; Liang Cheng; Timothy A Masterson; Xiaoqi Liu; Timothy L Ratliff; Ji-Xin Cheng
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

Review 3.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

4.  Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.

Authors:  Paolo Strati; Sameer A Parikh; Kari G Chaffee; Neil E Kay; Timothy G Call; Sara J Achenbach; James R Cerhan; Susan L Slager; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2017-06-04       Impact factor: 6.998

5.  Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin.

Authors:  Jonathan S Rink; Shuo Yang; Osman Cen; Tim Taxter; Kaylin M McMahon; Sol Misener; Amir Behdad; Richard Longnecker; Leo I Gordon; C Shad Thaxton
Journal:  Mol Pharm       Date:  2017-10-03       Impact factor: 4.939

Review 6.  Molecular Subtyping in Diffuse Large B Cell Lymphoma: Closer to an Approach of Precision Therapy.

Authors:  Reem Karmali; Leo I Gordon
Journal:  Curr Treat Options Oncol       Date:  2017-02

7.  Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway.

Authors:  Hyeon Jeong Lee; Jie Li; Renee E Vickman; Junjie Li; Rui Liu; Abigail C Durkes; Bennett D Elzey; Shuhua Yue; Xiaoqi Liu; Timothy L Ratliff; Ji-Xin Cheng
Journal:  Mol Cancer Res       Date:  2018-03-15       Impact factor: 5.852

8.  Biomimetic, synthetic HDL nanostructures for lymphoma.

Authors:  Shuo Yang; Marina G Damiano; Heng Zhang; Sushant Tripathy; Andrea J Luthi; Jonathan S Rink; Andrey V Ugolkov; Amareshwar T K Singh; Sandeep S Dave; Leo I Gordon; C Shad Thaxton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

Review 9.  Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators.

Authors:  Maximillian A Rogers; Jay Liu; Bao-Liang Song; Bo-Liang Li; Catherine C Y Chang; Ta-Yuan Chang
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-12       Impact factor: 4.292

Review 10.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.